X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24240) 24240
Book Review (3609) 3609
Publication (2150) 2150
Newsletter (167) 167
Newspaper Article (105) 105
Book Chapter (61) 61
Conference Proceeding (36) 36
Dissertation (25) 25
Book / eBook (22) 22
Data Set (6) 6
Magazine Article (3) 3
Presentation (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23031) 23031
humans (22039) 22039
female (11954) 11954
colorectal cancer (11885) 11885
male (11141) 11141
oncology (11068) 11068
cancer (10452) 10452
middle aged (9347) 9347
aged (8465) 8465
colorectal-cancer (6728) 6728
adult (5946) 5946
tumors (5731) 5731
animals (5563) 5563
colorectal neoplasms - pathology (5283) 5283
prognosis (4334) 4334
metastasis (4208) 4208
research (4092) 4092
surgery (4089) 4089
analysis (4034) 4034
gastroenterology & hepatology (3960) 3960
aged, 80 and over (3804) 3804
medicine (3795) 3795
mice (3734) 3734
multidisciplinary sciences (3581) 3581
research article (3562) 3562
expression (3415) 3415
medicine & public health (3352) 3352
cell line, tumor (3301) 3301
colorectal neoplasms - genetics (3280) 3280
science (3140) 3140
carcinoma (2906) 2906
colorectal carcinoma (2870) 2870
genetic aspects (2855) 2855
health aspects (2837) 2837
gene expression (2823) 2823
risk factors (2800) 2800
chemotherapy (2793) 2793
immunohistochemistry (2748) 2748
colorectal neoplasms - immunology (2743) 2743
survival (2731) 2731
gastroenterology (2661) 2661
care and treatment (2602) 2602
immunology (2559) 2559
colon cancer (2494) 2494
proteins (2483) 2483
colon (2439) 2439
neoplasm staging (2379) 2379
mutation (2370) 2370
apoptosis (2350) 2350
colon-cancer (2220) 2220
pathology (2209) 2209
hepatology (2168) 2168
patients (2147) 2147
breast-cancer (2145) 2145
colorectal neoplasms - metabolism (2131) 2131
development and progression (2070) 2070
cell biology (2051) 2051
internal medicine (1952) 1952
gene expression regulation, neoplastic (1927) 1927
treatment outcome (1914) 1914
studies (1869) 1869
medical prognosis (1860) 1860
genes (1847) 1847
medical research (1773) 1773
metastases (1744) 1744
colorectal neoplasms - drug therapy (1737) 1737
diagnosis (1723) 1723
retrospective studies (1706) 1706
cells (1669) 1669
risk (1634) 1634
oncology, experimental (1619) 1619
cancers and neoplasms (1597) 1597
biomarkers (1586) 1586
cancer therapies (1585) 1585
immunotherapy (1567) 1567
breast cancer (1562) 1562
colonic neoplasms - pathology (1559) 1559
biology (1544) 1544
signal transduction (1518) 1518
abridged index medicus (1444) 1444
cancer research (1437) 1437
genetics (1381) 1381
cell proliferation (1376) 1376
inflammation (1368) 1368
colorectal neoplasms - diagnosis (1334) 1334
kinases (1333) 1333
mortality (1333) 1333
case-control studies (1276) 1276
article (1245) 1245
medicine, research & experimental (1242) 1242
microsatellite instability (1232) 1232
survival analysis (1224) 1224
medicine and health sciences (1200) 1200
dna (1195) 1195
colorectal neoplasms - surgery (1189) 1189
deoxyribonucleic acid--dna (1182) 1182
neoplasm metastasis (1179) 1179
adenocarcinoma (1173) 1173
survival rate (1172) 1172
adenocarcinoma - pathology (1171) 1171
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24197) 24197
Japanese (91) 91
Chinese (68) 68
German (44) 44
French (38) 38
Spanish (24) 24
Italian (18) 18
Polish (17) 17
Russian (17) 17
Korean (6) 6
Bulgarian (4) 4
Czech (4) 4
Danish (4) 4
Romanian (3) 3
Croatian (2) 2
Dutch (2) 2
Hungarian (2) 2
Swedish (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Portuguese (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 07/2017, Volume 357, Issue 6349, pp. 409 - 413
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed... 
CELL LUNG-CANCER | SURVIVAL | COLORECTAL CARCINOMAS | RECEIVING NIVOLUMAB | IMMUNOTHERAPY | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | LONG-TERM SAFETY | NEOANTIGENS | CHECKPOINT BLOCKADE | LYMPHOCYTES | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neoplastic Syndromes, Hereditary - mortality | Young Adult | Colorectal Neoplasms - therapy | Brain Neoplasms - immunology | DNA Mismatch Repair | Aged, 80 and over | Adult | Female | Neoplastic Syndromes, Hereditary - genetics | Brain Neoplasms - mortality | Biomarkers, Tumor - antagonists & inhibitors | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm - immunology | Brain Neoplasms - genetics | Disease-Free Survival | Colorectal Neoplasms - immunology | Cell Cycle Checkpoints - drug effects | Brain Neoplasms - therapy | Neoplastic Syndromes, Hereditary - therapy | T-Lymphocytes - immunology | Aged | Mutation | Programmed Cell Death 1 Receptor - immunology | Colorectal cancer | Genetic aspects | Nucleotide sequencing | Health aspects | DNA repair | Methods | Tumors | DNA sequencing | Yeast | PD-1 protein | Antibodies | Clinical trials | Genomes | Functional analysis | Lymphocytes T | Patients | Survival | Colon cancer | Immune checkpoint | Immunotherapy | Mismatch repair | Pancreatic cancer | Biomarkers | Bioindicators | Colon | Solid tumors | Genetic recombination | Repair | Cancer | Apoptosis | Index Medicus
Journal Article
Immunity, ISSN 1074-7613, 10/2013, Volume 39, Issue 4, pp. 782 - 795
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 538 - 543
Most patients with colorectal cancer die as a result of the disease spreading to other organs. However, no prevalent mutations have been associated with... 
STEM-CELLS | GENE | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | MOUSE | LEADS | RECEPTOR | MICE | GROWTH-FACTOR | TUMORIGENESIS | EXPRESSION | Intestines - drug effects | Colonic Neoplasms - genetics | Intestinal Mucosa - metabolism | Colonic Neoplasms - drug therapy | Humans | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Stem Cells - metabolism | Th1 Cells - immunology | T-Lymphocytes, Cytotoxic - drug effects | Neoplasm Metastasis - drug therapy | Neoplasm Metastasis - immunology | Colonic Neoplasms - immunology | Immunotherapy | Transforming Growth Factor beta - antagonists & inhibitors | Female | Liver Neoplasms - secondary | Disease Models, Animal | T-Lymphocytes, Cytotoxic - immunology | Transforming Growth Factor beta - immunology | Tumor Microenvironment - drug effects | Th1 Cells - drug effects | Intestines - pathology | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Drug Synergism | Tumor Microenvironment - immunology | Neoplasm Metastasis - genetics | Animals | Cell Differentiation - drug effects | Neoplasm Metastasis - pathology | Colonic Neoplasms - pathology | Alleles | Immune Evasion - drug effects | Stem Cells - drug effects | Stem Cells - pathology | Mice | Mutation | T-Lymphocytes, Cytotoxic - cytology | PD-1 protein | Liver | Colorectal carcinoma | Colorectal cancer | Stem cell transplantation | Cytotoxicity | Lymphocytes T | Metastasis | Metastases | Colon cancer | Intestine | Lymphocytes | Genetic analysis | Fibroblasts | Colon | Inhibition | Growth factors | Phenotypes | Data analysis | Liver diseases | Microsatellites | Organs | Gene expression | Patients | Signaling | Immune checkpoint | PD-L1 protein | Stem cells | Tumors | Cancer | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2013, Volume 110, Issue 24, pp. 9862 - 9867
The microbiota is pivotal in the pathogenesis of inflammatory bowel disease (IBD)-associated inflammation-induced colorectal cancer (CRC), yet mechanisms for... 
Microorganisms | Microbiota | Receptors | Epithelial cells | Colorectal cancer | Mice | Inflammation | Colitis | Tumors | Cancer | colon cancer | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | COLITIS-ASSOCIATED CANCER | NLRP3 INFLAMMASOME | INTESTINAL INFLAMMATION | ASC | COLORECTAL-CANCER | DISEASE | COLON INFLAMMATION | MICE | GUT FLORA | TUMORIGENESIS | microflora | Neoplasms - metabolism | Interleukin-18 - immunology | Inflammasomes - metabolism | Colitis - genetics | Colorectal Neoplasms - genetics | Male | Chemokine CCL5 - deficiency | Epithelium - immunology | Signal Transduction - immunology | Inflammation - metabolism | Neoplasms - genetics | Colonoscopy | Epithelium - microbiology | Female | Colitis - immunology | Interleukin-6 - metabolism | Colorectal Neoplasms - metabolism | Epithelium - metabolism | Interleukin-6 - genetics | Mice, Inbred C57BL | Interleukin-18 - deficiency | Inflammation - immunology | Receptors, Cell Surface - immunology | Mice, Knockout | Animals | Colorectal Neoplasms - immunology | Neoplasms - immunology | Inflammasomes - immunology | Receptors, Cell Surface - deficiency | Chemokine CCL5 - genetics | Colitis - metabolism | Interleukin-6 - immunology | Inflammation - genetics | Metagenome - immunology | Interleukin-18 - genetics | Chemokine CCL5 - immunology | Receptors, Cell Surface - genetics | Physiological aspects | Development and progression | Health aspects | Interleukin-6 | Inflammatory bowel disease | Cytokines | Microbiology | Pathogenesis | Chemokines | Index Medicus | Biological Sciences
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2014, Volume 20, Issue 19, pp. 5064 - 5074
Journal Article
Science, ISSN 0036-8075, 11/2015, Volume 350, Issue 6263, pp. 972 - 978
Journal Article
Immunity, ISSN 1074-7613, 12/2017, Volume 47, Issue 6, pp. 1083 - 1099.e6
The immunosuppressive protein PD-L1 is upregulated in many cancers and contributes to evasion of the host immune system. The relative importance of the tumor... 
PD-L1 | TTP | KRAS | RAS | tristetraprolin | immunotherapy | CELL LUNG-CANCER | ACTIVATED PROTEIN-KINASE | EPITHELIAL-CELLS | TRISTETRAPROLIN | MELANOMA-CELLS | TNF-ALPHA | IMMUNOLOGY | EXPRESSION | CHECKPOINT BLOCKADE | Proto-Oncogene Proteins p21(ras) - immunology | Neoplasm Transplantation | RNA, Messenger - immunology | Tumor Escape | Proto-Oncogene Proteins p21(ras) - genetics | Tristetraprolin - immunology | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Intracellular Signaling Peptides and Proteins - immunology | Lung Neoplasms - pathology | Male | Female | Intracellular Signaling Peptides and Proteins - genetics | Lung Neoplasms - genetics | Signal Transduction | MAP Kinase Kinase Kinases - genetics | Mice, Inbred C57BL | RNA, Messenger - genetics | Protein-Serine-Threonine Kinases - genetics | Epithelial Cells - pathology | RNA Cleavage | RNA Stability | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | MAP Kinase Kinase Kinases - immunology | Lung Neoplasms - immunology | Animals | Colorectal Neoplasms - immunology | Tristetraprolin - genetics | Epithelial Cells - immunology | Cell Line, Tumor | Protein Binding | Protein-Serine-Threonine Kinases - immunology | Mice | Mice, Inbred BALB C | Colorectal Neoplasms - pathology | Messenger RNA | Gastrointestinal diseases | Immunotherapy | Colorectal cancer | Cellular signal transduction | Cancer | Protein binding | Transcription factors | Cytokines | Lung cancer | Genomes | Ras protein | Kinases | Ribonucleic acid--RNA | Patients | Proteins | Signal transduction | Immunosuppression | DNA methylation | Tumor necrosis factor-TNF | Ligands | Protein expression | Mutation | Oncogenes | Tumors | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 11/2012, Volume 491, Issue 7423, pp. 254 - 258
Approximately 2% of colorectal cancer is linked to pre-existing inflammation known as colitis-associated cancer, but most develops in patients without... 
COLITIS | PROMOTES COLON TUMORIGENESIS | COLORECTAL-CANCER | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | HELPER-CELLS | MOUSE MODEL | APC(MIN/+) MICE | RECEPTOR | DIFFERENTIATION | CUTTING EDGE | Inflammation - pathology | Adenoma - genetics | Colorectal Neoplasms - genetics | Humans | Colitis - complications | Interleukin-17 - immunology | Interleukin-23 - deficiency | Tumor Microenvironment | Adenoma - immunology | Adenoma - microbiology | Genes, APC | Interleukin-23 - genetics | Myeloid Cells - immunology | Cell Division | Myeloid Differentiation Factor 88 - immunology | Toll-Like Receptors - metabolism | Disease Models, Animal | Bacteria - metabolism | Inflammation - microbiology | Signal Transduction | Mice, Inbred C57BL | Toll-Like Receptors - immunology | Interleukin-17 - genetics | Colorectal Neoplasms - microbiology | Inflammation - immunology | beta Catenin - metabolism | Interleukin-23 - immunology | Disease-Free Survival | Animals | Colorectal Neoplasms - immunology | Adenoma - pathology | Inflammation - genetics | Myeloid Cells - metabolism | Bacteria - pathogenicity | Mice | Cell Transformation, Neoplastic - pathology | Colorectal Neoplasms - pathology | Myeloid Differentiation Factor 88 - metabolism | Development and progression | Cellular signal transduction | Research | Interleukins | Properties | Tumors | Index Medicus
Journal Article
Molecular Therapy, ISSN 1525-0016, 05/2017, Volume 25, Issue 5, pp. 1248 - 1258
Chimeric antigen receptor T (CAR-T) cells have shown promising efficacy in treatment of hematological malignancies, but its applications in solid tumors need... 
safety and efficacy | phase I | dose escalating | colorectal carcinoma | CAR-T | CEA | MEDICINE, RESEARCH & EXPERIMENTAL | CD8(+) | RESPONSE CRITERIA | VIVO | SUBSETS | CELL THERAPY | CHIMERIC ANTIGEN RECEPTOR | ANTITUMOR-ACTIVITY | B-CELL | IMMUNOTHERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | CARCINOEMBRYONIC ANTIGEN | Dose-Response Relationship, Immunologic | Humans | Middle Aged | Mutant Chimeric Proteins - genetics | Carcinoembryonic Antigen - genetics | Male | Liver Neoplasms - therapy | Lymphocyte Depletion | T-Lymphocytes - transplantation | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Colorectal Neoplasms - therapy | Neoplasm Recurrence, Local - diagnostic imaging | Protein Engineering | Female | Receptors, Antigen, T-Cell - immunology | Liver Neoplasms - secondary | Gene Expression | Immunotherapy, Adoptive | Carcinoembryonic Antigen - immunology | Lymphocyte Activation | Adenocarcinoma - immunology | Neoplasm Recurrence, Local - therapy | Liver Neoplasms - immunology | Colorectal Neoplasms - diagnostic imaging | Liver Neoplasms - diagnostic imaging | Adenocarcinoma - secondary | Magnetic Resonance Imaging | Colorectal Neoplasms - immunology | Adenocarcinoma - therapy | T-Lymphocytes - cytology | Mutant Chimeric Proteins - immunology | T-Lymphocytes - immunology | Aged | Receptors, Antigen, T-Cell - genetics | Adenocarcinoma - diagnostic imaging | Colorectal Neoplasms - pathology | Cytotoxicity, Immunologic | Cell proliferation | Antigens | Research & development--R&D | Liver | Colorectal carcinoma | Exploration | Lymphocytes T | Metastasis | Radiation therapy | Patients | Embryos | Fever | Metastases | Inflammatory bowel disease | Carcinoembryonic antigen | Magnetic resonance imaging | Computed tomography | Lymphocytes | Peripheral blood | Nonsteroidal anti-inflammatory drugs | Solid tumors | Positron emission tomography | Tumors | Index Medicus | Original
Journal Article